Fortis Group Advisors’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,780
Closed -$462K 518
2024
Q3
$462K Buy
2,780
+173
+7% +$26.2K 0.09% 132
2024
Q2
$347K Buy
2,607
+349
+15% +$42K 0.07% 143
2024
Q1
$237K Buy
+2,258
New +$203K 0.04% 182

Other funds holding THC

Fortis Group Advisors's THC Position: Q4 2024 in Review

Fortis Group Advisors sold out of Tenet Healthcare (THC) in Q4 2024, closing a stake of 2,780 shares — an estimated $462K sold.

Fortis Group Advisors first reported a position in THC in Q1 2024 and held it in 3 quarters. The position peaked at $462K in Q3 2024. 577 funds tracked by Wall St. Rank hold THC as of Q4 2024.

  • Fortis Group Advisors reported no remaining Tenet Healthcare position as of Q4 2024 after selling out during the quarter.
  • Fortis Group Advisors sold 2,780 Tenet Healthcare shares in Q4 2024, an estimated $462K.
  • Fortis Group Advisors first reported a position in Tenet Healthcare in Q1 2024 and held it in 3 quarters.
  • Fortis Group Advisors's Tenet Healthcare position peaked at $462K in Q3 2024.
  • 577 funds tracked by Wall St. Rank held Tenet Healthcare as of Q4 2024.

Based on Fortis Group Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.